Señales en vivo de ASND | Maximiza tus Ganancias con Getagraph.com

COMPRAR 19239 min ago

@ $144.01

Emitido: 24 abr 2024 @ 09:31

Retorno: -5.57%

Señal anterior: abr 22 - 13:18

Señal anterior: Vender

Retorno: 0.54 %

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 16:00):

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD)...

Stats
Volumen de hoy	501 959
Volumen promedio	335 216
Capitalización de mercado	7.70B
EPS	$-1.650 ( 2024-05-02 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-14.22
ATR14	$0.164 (0.12%)

Volumen Correlación

Largo: 0.14 (neutral)

Corto: -0.83 (strong negative)

Signal:(49.875) Neutral

Ascendis Pharma A/S Correlación

10 Correlaciones Más Positivas
LMPX	0.937
ATHN	0.927
FXCO	0.923
FTNT	0.91
WYNN	0.908
ASRV	0.906
ZYXI	0.906
WABC	0.903
CYBR	0.902
ISEM	0.901

10 Correlaciones Más Negativas
BMEA	-0.955
TMTS	-0.938
CLXT	-0.936
ALDX	-0.925
SMFL	-0.913
RTPY	-0.904
COCO	-0.899
RIVE	-0.898
MOTNU	-0.887
POAI	-0.887

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ascendis Pharma A/S Correlación - Moneda/Commodity

0.13
( neutral )

0.37
( neutral )

0.00
( neutral )

-0.20
( neutral )

0.11
( neutral )

0.00
( neutral )

Ascendis Pharma A/S Finanzas

Annual	2023
Ingresos:	$266.72M
Beneficio Bruto:	$222.32M (83.36 %)
EPS:	$-8.55

FY	2023
Ingresos:	$266.72M
Beneficio Bruto:	$222.32M (83.36 %)
EPS:	$-8.55

FY	2022
Ingresos:	$51.17M
Beneficio Bruto:	$39.04M (76.28 %)
EPS:	$-10.40

FY	2021
Ingresos:	$7.78M
Beneficio Bruto:	$4.26M (54.71 %)
EPS:	$-7.00

Financial Reports:

No articles found.

Ascendis Pharma A/S

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.